跳至主要内容
临床试验/jRCT1050240216
jRCT1050240216进行中(未招募)不适用

A cross-sectional web survey study to clarify reality of chronic rhinosinusitis with nasal polyps treatment satisfaction and QOL in patients with intractable ECRS patient(COMPASS study) (COMPASS study)

AstraZeneca K.K.0 个研究点目标入组 200 人开始时间: 2024年12月26日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18age old over 至 No limit(—)

入选标准

  • Provision of signed informed consent on the website
  • Aged >=18 years at the time of answering the web survey
  • History of ECRS diagnosis more than 3 months prior to the time of answering the web survey
  • The patients who have been receiving CRS related treatment
  • The patients who have been issued a beneficiary certificate for intractable ECRS

排除标准

  • 未提供

结局指标

主要结局

-

Proportion of patient who are satisfied with current ECRS treatment

次要结局

  • Mean SNOT-22 score (total and each subdomain score)
  • Proportion of patient who are satisfied with current ECRS treatment by biologics use/non biologics use

研究者

相似试验